• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Increase of the target inhibition effects on FLT3 based on the glycosylation and cellular localization status

Research Project

Project/Area Number 21591198
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionNagoya University

Principal Investigator

KIYOI Hitoshi  名古屋大学, 大学院・医学系研究科, 准教授 (90314004)

Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
KeywordsFLT3 / チロシンキナーゼ / 糖鎖修飾 / 阻害剤 / 細胞内局在 / 併用療法 / 白血病
Research Abstract

We identified that the inhibition of glycosylation machinery reduced the cell surface expression of wild type FLT3 and induced cell death through the inhibition of activated STATs in wild type FLT3-expressing cells, but not in mutant FLT3-expressing cells. We demonstrated that the glycosylation is essential for auto-phosphorylation via FL-stimulation in wild type FLT3, and that mutant FLT3 is auto-phosphorylated within the cytoplasm before the glycosylation resulting in the cell proliferation via STATs phosphorylations.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (72 results)

All 2012 2011 2010 2009

All Journal Article (46 results) (of which Peer Reviewed: 46 results) Presentation (26 results)

  • [Journal Article] Using peripheral blood circulating DNA stodetect CpG global methylation status and genetic mutations in patients with myelo dysplastic syndrome2012

    • Author(s)
      Iriyama C, Tomita A, Hoshino H, Shirahata M, Furukawa-Hibi Y, Yamada K, Kiyoi H, Naoe T.
    • Journal Title

      Biochem Biophys Res Commun

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Long-term outcome of imatinib therapy, with assessment of its dosage and blood levels, for chronic myelogenous leukemia2012

    • Author(s)
      Ohnishi K, Nakaseko C, Takeuchi J, Fujisawa S, Nagai T, Yamazaki H, Tauchi T, Imai K, Mori N, Yagasaki F, Maeda Y, Usui N, Miyazaki Y, Miyamura K, Kiyoi H, Ohtake S, Naoe T.
    • Journal Title

      Cancer Sci

      Volume: (in press)

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Y654 ofβ-catenin is essential for FLT3/ITD-related tyrosine phosphorylation and nuclear localization ofβ-catenin Eur J Haematol2012

    • Author(s)
      Kajiguchi T, Katsumi A, Tanizaki R, Kiyoi H, Naoe T.
    • Volume
      (in press)
    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Molecular lesions in childhood and adult acute megakaryoblastic leukaemia2012

    • Author(s)
      Hama A, Muramatsu H, Makishima H, Sugimoto Y, Szpurka H, Jasek M, OKeefe C, Takahashi Y, Sakaguchi H, Doisaki S, Shimada A, Watanabe N, Kato K, Kiyoi H, Naoe T, Kojima S, Maciejewski JP.
    • Journal Title

      Br J Haematol

      Volume: 156 Pages: 316-325

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome2012

    • Author(s)
      Chisako Iriyama
    • Journal Title

      Biochem Biophys Res Commun

      Volume: (in press) Issue: 4 Pages: 662-669

    • DOI

      10.1016/j.bbrc.2012.02.071

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Long-term outcome of imatinib therapy, with assessment of its dosage and blood levels, for chronic myelogenous leukemia2012

    • Author(s)
      Ohnishi K, et al
    • Journal Title

      Cancer Science

      Volume: (In press) Issue: 6 Pages: 1071-1078

    • DOI

      10.1111/j.1349-7006.2012.02253.x

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Y654 of β-catenin is essential for FLT3/ITD-related tyrosine phosphorylation and nuclear localization of β-catenin2012

    • Author(s)
      Tomohiro Kajiguchi
    • Journal Title

      Eur J Haematol

      Volume: (in press) Issue: 4 Pages: 314-320

    • DOI

      10.1111/j.1600-0609.2011.01738.x

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment2011

    • Author(s)
      Goto E, Tomita A, Hayakawa F, Atsumi A, Kiyoi H, Naoe T.
    • Journal Title

      Blood

      Volume: 118 Pages: 1600-1609

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Japan Adult Leukemia Study Group. Phase Itrial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia(AML): Japan Adult Leukemia Study Group(JALSG)-AML206 study2011

    • Author(s)
      Usui N, Takeshita A, Nakaseko C, Dobashi N, Fujita H, Kiyoi H, Kobayashi Y, Sakura T, Yahagi Y, Shigeno K, Ohwada C, Miyazaki Y, Ohtake S, Miyawaki S, Naoe T, Ohnishi K.
    • Journal Title

      Cancer Sci

      Volume: 102 Pages: 1358-1365

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Anovel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib-resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis2011

    • Author(s)
      Sakai K, Ishikawa Y, Mori Y, Kobayashi M, Iriyama C, Ozawa Y, Suzuki T, Minami Y, Ishikawa K, Kaneda N, Naoe T, Kiyoi H.
    • Journal Title

      Int J Hematol

      Volume: 93 Pages: 237-242

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia2011

    • Author(s)
      Ishikawa Y, Kiyoi H, Naoe T.
    • Journal Title

      Leuk Res

      Volume: 35 Pages: 685-688

    • Related Report
      2011 Annual Research Report 2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] A randomized comparison of four courses of standard-dose multiagent chemotherapy versus three courses of high-dose cytarabine alone in post-remission therapy for acute myeloid leukemia in adults : the JALSG AML201 study2011

    • Author(s)
      Miyawaki S, Ohtake S, Fujisawa S, Kiyoi H, Shinagawa K, Usui N, Sakura T, Miyamura K, Nakaseko C, Miyazaki Y, Fujieda A, Nagai T, Yamane T, Taniwaki M, Takahashi M, Yagasaki F, Kimura Y, Asou N, Sakamaki H, Handa H, Honda S, Ohnishi K, Naoe T, Ohno R.
    • Journal Title

      Blood

      Volume: 117 Pages: 2366-2372

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia : JALSG AML201 Study2011

    • Author(s)
      Ohtake S, Miyawaki S, Fujita H, Kiyoi H, Shinagawa K, Usui N, Okumura H, Miyamura K, Nakaseko C, Miyazaki Y, Fujieda A, Nagai T, Yamane T, Taniwaki M, Takahashi M, Yagasaki F, Kimura Y, Asou N, Sakamaki H, Handa H, Honda S, Ohnishi K, Naoe T, Ohno R.
    • Journal Title

      Blood

      Volume: 117 Pages: 2358-2365

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] FLT3/ITD regulate sleukaemia cell adhesion throughα4β1integrin and Pyk2 signaling2011

    • Author(s)
      Katsumi A, Kiyoi H, Abe A, Tanizaki R, Iwasaki T, Kobayashi M, Matsushita T, Senga T, Kohno T, Kojima T, Kaibuchi K, Hamaguchi M, Naoe T.
    • Journal Title

      Eur J Haematol

      Volume: 86 Pages: 191-198

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Virus-associated hemophagocytic syndrome caused by pandemic swine-origin influenza A (H1N1) in a patient after unrelated bone marrow transplantation2011

    • Author(s)
      Akira Katsumi
    • Journal Title

      J Clin Exp Hematop

      Volume: 51 Pages: 63-65

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia study Group (JALSG)-AML206 study2011

    • Author(s)
      Usui N, Ohnishi K, et al
    • Journal Title

      Cancer Science

      Volume: 102(7) Issue: 7 Pages: 1358-65

    • DOI

      10.1111/j.1349-7006.2011.01957.x

    • NAID

      10029295449

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib-resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis.2011

    • Author(s)
      Katsuya Sakai
    • Journal Title

      Int J Hematol

      Volume: 93 Pages: 237-242

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia.2011

    • Author(s)
      Yuichi Ishikawa
    • Journal Title

      Leuk Res

      Volume: 35

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A randomized comparison of four courses of standard-dose multiagent chemotherapy versus three courses of higb-dose cyarabine alone in post-remission therapy for acute myeloid leukemia in adults : the JALSG AML201 study.2011

    • Author(s)
      Syuichi Miyawaki
    • Journal Title

      Blood

      Volume: 117 Pages: 2366-2372

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Randomized study of induction therapy comparing standard-dose idarubicin witk high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia : JALSG AML201 Study.2011

    • Author(s)
      Satoshi Ohtake
    • Journal Title

      Blood

      Volume: 117 Pages: 2358-2365

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia2010

    • Author(s)
      Tsujimura A, Kiyoi H, Shiotsu Y, Ishikawa Y, Mori Y, Ishida H, Toki T, Ito E, Naoe T.
    • Journal Title

      Int J Hematol

      Volume: 92 Pages: 624-633

    • NAID

      10027673999

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Trough plasma concentration of imatinib reflects BCR-ABL kinase in hibitory activity and clinical response in chronic-phase chronic myeloid leukemia : a report from the BINGO study2010

    • Author(s)
      Ishikawa Y, Kiyoi H, Watanabe K, Miyamura K, Nakano Y, Kitamura K, Kohno A, Sugiura I, Yokozawa T, Hanamura A, Yamamoto K, Iida H, Emi N, Suzuki R, Ohnishi K, Naoe T.
    • Journal Title

      Cancer Sci

      Volume: 101 Pages: 2186-2192

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Array-based genomic resequencing of human leukemia2010

    • Author(s)
      Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, Choi YL, Ueno T, Soda M, Hamada T, Haruta H, Takada S, Miyazaki Y, Kiyoi H, Ito E, Naoe T, Tomonaga M, Toyota M, Tajima S, Iwama A, Mano H.
    • Journal Title

      Oncogene

      Volume: 29 Pages: 3723-3731

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma2010

    • Author(s)
      Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R.
    • Journal Title

      J Clin Oncol

      Volume: 28 Pages: 1591-8

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rgammac mice2010

    • Author(s)
      Tanizaki R, Nomura Y, Miyata Y, Minami Y, Abe A, Hanamura A, Sawa M, Murata M, Kiyoi H, Matsushita T, Naoe T.
    • Journal Title

      Cancer Sci

      Volume: 101 Pages: 631-638

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] FLT3/ITD regulates leukaemia cell adhesion through α4β1 integrin and Pyk2 signaling.2010

    • Author(s)
      Akira Katsumi
    • Journal Title

      Eur J Haematol

      Volume: 86 Pages: 191-198

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment.2010

    • Author(s)
      Yosuke Minami
    • Journal Title

      Int J Hematol

      Volume: 92 Pages: 664-666

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia.2010

    • Author(s)
      Akane Tsujimura
    • Journal Title

      Int J Hematol

      Volume: 92 Pages: 624-633

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : a report from the BINGO study.2010

    • Author(s)
      Yuichi Ishikawa
    • Journal Title

      Cancer Sci

      Volume: 101 Pages: 2186-2192

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Imatinib for newiy diagnosed chronic-phase chronic myeloid leukemia : results of aprospective study in Japan.2010

    • Author(s)
      Tadashi Nagai
    • Journal Title

      Int J Hematol

      Volume: 92 Pages: 111-117

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Array-based genomic resequencing of human leukemia.2010

    • Author(s)
      Yoshito Yamashita
    • Journal Title

      Oncogene

      Volume: 29 Pages: 3723-3781

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma.2010

    • Author(s)
      Kazuhito Yamamoto
    • Journal Title

      J Clin Oncol 28

      Pages: 1591-1598

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabinc in adult acute myeloid leukemia : the JALSG AML95 study.2010

    • Author(s)
      Satoshi Ohtake
    • Journal Title

      Int J Hematol 91

      Pages: 276-283

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] BCR-ABL-indcpcndcnt and RAS/MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.2010

    • Author(s)
      Momoko Suzuki
    • Journal Title

      Eur J Haematol 84

      Pages: 229-238

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD.2010

    • Author(s)
      Yoshihiro Inamoto
    • Journal Title

      Bone Marrow Transplant 45

      Pages: 363-369

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Escape mechanisms from antibody therapy to lymphoma cells : down regulation of CD 20 mRNA by recruitment of the HDAC complex and not by DNA methylation2009

    • Author(s)
      Sugimoto T, Tomita A, Hiraga J, Shimada K, Kiyoi H, Kinoshita T, Naoe T.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 390 Pages: 48-53

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] KW-2449, a novel multi-kinase in hibit or, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutatedBCR/ABL translocation2009

    • Author(s)
      Shiotsu Y, Kiyoi H, Ishikawa Y, Tanizaki R, Shimizu M, Umehara H, Ishii K, Mori Y, Ozeki K, Minami Y, Abe A, Maeda H, Akiyama T, Kanda Y, Sato Y, Akinaga S, Naoe T.
    • Journal Title

      Blood

      Volume: 114 Pages: 1607-1617

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia2009

    • Author(s)
      Ishikawa Y, Kiyoi H, Tsujimura A, Miyawaki S, Miyazaki Y, Kuriyama K, Tomonaga M, Naoe T.
    • Journal Title

      Eur J Haematol

      Volume: 83 Pages: 90-98

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemo the rapies : its prevalence and clinical significance2009

    • Author(s)
      Hiraga J, Tomita A, Sugimoto T, Shimada K, Ito M, Nakamura S, Kiyoi H, Kinoshita T, Naoe T.
    • Journal Title

      Blood

      Volume: 113 Pages: 4885-4893

    • Related Report
      2011 Final Research Report
    • Peer Reviewed
  • [Journal Article] Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rgammac mice.2009

    • Author(s)
      Ryohei Tanizaki
    • Journal Title

      Cancer Sci 101

      Pages: 631-634

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Escape mechanisms from antibody therapy to lymphoma cells : downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation.2009

    • Author(s)
      Takumi Sugimoto
    • Journal Title

      Biochem Biophys Res Commun 390

      Pages: 48-53

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] KW-2449, a novel multi-kinase inhibitor, suppresses the growth of leukcmia cclls with FLT3 mutations or T3151-mutated BCR/ABL translocation.2009

    • Author(s)
      Yukimasa Shiotsu
    • Journal Title

      Blood 114

      Pages: 1607-1617

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] CMC-544(inotuzumab ozogamicin)shows less effect on multidrug resistant cells : analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma.2009

    • Author(s)
      Akihiro Takeshita
    • Journal Title

      Br J Haemato 146

      Pages: 34-43

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] CMC-544(inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calic heamicin, alters the levels of target molecules of malignant B-cells.2009

    • Author(s)
      Akihiro Takeshita
    • Journal Title

      Leukemia 146

      Pages: 34-43

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.2009

    • Author(s)
      Yuichi Ishikawa
    • Journal Title

      Eur J Haematol 83

      Pages: 90-98

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Down-regulation of CD20 expression in B-ccll lymphoma cells after treatment with rituximab-containing combination chemotherapies : its prevalence and clinical significance.2009

    • Author(s)
      Junji Hiraga
    • Journal Title

      Blood 113

      Pages: 4885-4893

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Presentation] DNMT3A and IDH1/2 Mutations Are Stable During the Progression of Acute Myeloid Leukemia2011

    • Author(s)
      Rika Kihara
    • Organizer
      American Society of Hematology 53rd Annual Meeting
    • Place of Presentation
      San Diego Convention Center (San Diego, USA)
    • Year and Date
      2011-12-11
    • Related Report
      2011 Annual Research Report
  • [Presentation] 急性骨髄性白血病における分子病態に基づく予後層別化と個別化治療2011

    • Author(s)
      清井仁
    • Organizer
      第49回日本癌治療学会総会(招待講演)
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2011-10-27
    • Related Report
      2011 Final Research Report
  • [Presentation] 急性骨髄性白血病における分子病態に基づく予後層別化と個別化治療2011

    • Author(s)
      清井仁
    • Organizer
      第49回日本癌治療学会総会
    • Place of Presentation
      名古屋国際会議場(愛知県)(招待講演)
    • Year and Date
      2011-10-27
    • Related Report
      2011 Annual Research Report
  • [Presentation] AML病態研究の進展と最近の治療エビデンス2011

    • Author(s)
      清井仁
    • Organizer
      第73回日本血液学会学術総会(招待講演)
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2011-10-16
    • Related Report
      2011 Final Research Report
  • [Presentation] AML病態研究の進展と最近の治療エビデンス2011

    • Author(s)
      清井仁
    • Organizer
      第73回日本血液学会学術総会
    • Place of Presentation
      名古屋国際会議場(愛知県)(招待講演)
    • Year and Date
      2011-10-16
    • Related Report
      2011 Annual Research Report
  • [Presentation] DNMT3A and IDH1/2 mutations are stable during the progression of acute myeloid leukemia2011

    • Author(s)
      Rika Kihara
    • Organizer
      第73回日本血液学会学術総会
    • Place of Presentation
      名古屋国際会議場(愛知県)
    • Year and Date
      2011-10-15
    • Related Report
      2011 Annual Research Report
  • [Presentation] DNMT3A and IDH1/2 mutations are stable during the progression of acute myeloid leukemia2011

    • Author(s)
      Rika Kihara
    • Organizer
      The XXV Symposium of the International Association for Comparative Eesearch on Leukemia and Related Diseases
    • Place of Presentation
      東京大学弥生会館(東京都)
    • Year and Date
      2011-09-15
    • Related Report
      2011 Annual Research Report
  • [Presentation] AML study in JALSG2011

    • Author(s)
      Hitoshi Kiyoi
    • Organizer
      The Korean Society of Hematology KSH and JALSG joint symposium
    • Place of Presentation
      Asan Medical Center (Seoul, Korea)(招待講演)
    • Year and Date
      2011-05-26
    • Related Report
      2011 Annual Research Report
  • [Presentation] 急性白血病の分子標的治療2010

    • Author(s)
      清井仁
    • Organizer
      第48回日本癌治療学会(招待講演)
    • Place of Presentation
      京都国際会議場(京都府)
    • Year and Date
      2010-10-30
    • Related Report
      2011 Final Research Report
  • [Presentation] 急性白血病の分子標的治療2010

    • Author(s)
      清井仁
    • Organizer
      第48回日本癌治療学会(シンポジウム)
    • Place of Presentation
      国立京都国際会館(京都)
    • Year and Date
      2010-10-30
    • Related Report
      2010 Annual Research Report
  • [Presentation] Prognostic classification and the development of individual therapy based on the genetic alterations in AML2010

    • Author(s)
      Hitoshi Kiyoi
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪府)
    • Year and Date
      2010-09-22
    • Related Report
      2011 Final Research Report
  • [Presentation] Prognostic classification and the development of individual therapy based on the genetic alterations in AML.2010

    • Author(s)
      Hitoshi Kiyoi
    • Organizer
      第69回日本癌学会総会(シンポジウム)
    • Place of Presentation
      大阪国際会議場(大阪)
    • Year and Date
      2010-09-22
    • Related Report
      2010 Annual Research Report
  • [Presentation] CD20-Negative Phenotypic Change In B-Cell Lymphoma Cells After Using Rituximab : Possibility of a Particular Clinicopathologic Phenomenon Post-Rituximab Extranodal CD20-Negative Lymphoma.2010

    • Author(s)
      Akihiro Tomita
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando, USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] Treatment with mTOR Inhibitor, Everolimus (RAD001) Overcomes Resistance to Imatinib In Ph-Leukemia Quiescent cells.2010

    • Author(s)
      Yachiyo Kuwatsuka
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando, USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] Biomarkers In Cell Death of Imatinib-Resistant Ph-Leukemia Cells During Treatment with mTOR Inhibitor, Everolimus.2010

    • Author(s)
      Miho Minami
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando, USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] Clathrin Assembly Protein CALM Plays a Key Role In Erythroid Differentiation Via Regulating Transferrin Receptor Endocytosis.2010

    • Author(s)
      Yuichi Ishikawa
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando, USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] Rapid Reduction of Chronic Myeloid Leukemia Stem Ceils After Treatment with Second-Generation BCR-ABL Kinase Inhibitors, Dasatinib and Nilotinib.2010

    • Author(s)
      Yosuke Minami
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando, USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] Sustained Superior Long-Term Outcomes of Imatinib Therapy In Japanese Patients with Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase : Sub-Analysis According to the Mean Daily Dose of Imatinib and the Piasma Trough Levels In JALSG CML202 Study After 66 Months Follow-up.2010

    • Author(s)
      Chiaki Nakaseko
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando, USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] Clinical Features and Outcomes of Elderly Patients with Acute Promyelocytic Leukemia (APL)-the Japan Adult Leukemia Study Group APL97 Study.2010

    • Author(s)
      Takaaki Ono
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando,USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] Transcriptional Activity of MEF/ELF4 on the HDM2 Promoter Is Enhanced by the Mutation of the NPM1 Gene.2010

    • Author(s)
      Koji Ando
    • Organizer
      The American Society of Hematology 52th Annual Meeting
    • Place of Presentation
      Orange County Convention Center, Orlando, USA
    • Related Report
      2010 Annual Research Report
  • [Presentation] MS4A1(CD20)Gene Expression Is Down-Regulated by Recruiting the Historie Deacetylase Protein Complex to the Promoter in the CD20-Negtive B-Lymphoma Cells After Treatment with Rituximab.2009

    • Author(s)
      Sugimoto Takumi
    • Organizer
      The American Society of Hematology 51th Annual Meeting
    • Place of Presentation
      New Orleans USA
    • Related Report
      2009 Annual Research Report
  • [Presentation] Treatment with Bortezomib Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent Cells.2009

    • Author(s)
      Kuwatsuka Yachiyo
    • Organizer
      The American Society of Hematology 51th Annual Meeting
    • Place of Presentation
      New Orleans USA
    • Related Report
      2009 Annual Research Report
  • [Presentation] Double Genetic Mutations in PML-Rara Fusion Gene Confirmed in a Patient Showing Resistance to All-Trans Retinoic Acid and Arsenic-Trioxide Therapy.2009

    • Author(s)
      Goto Emi
    • Organizer
      The American Society of Hematology 51th Annual Meeting
    • Place of Presentation
      New Orleans USA
    • Related Report
      2009 Annual Research Report
  • [Presentation] FL-Dependent Wild-Type FLT3 Signals Reduce the Inhibitory Effects of FET3 Inhibitors On Wild-Type and Mutant FLT3 Co-Expressing Cel.2009

    • Author(s)
      Mori Yumiko
    • Organizer
      The American Society of Hematology 51th Annual Meeting
    • Place of Presentation
      New Orleans USA
    • Related Report
      2009 Annual Research Report
  • [Presentation] FLT3/ITD Regulates Leukemia Cell Adhesion through α4β1 Integrin and Pyk2 Signalin.2009

    • Author(s)
      Katsumi Akira
    • Organizer
      The American Society of Hematology 51th Annual Meeting
    • Place of Presentation
      New Orleans USA
    • Related Report
      2009 Annual Research Report
  • [Presentation] Treatment with mTOR Inhibitor, Everolimus(RAD001)Overcomes Resistance to Imatinib in Ph-Leukemia Quiescent or T315I-Mutated Cells.2009

    • Author(s)
      Minami Yousuke
    • Organizer
      The American Society of Hematology 51th Annual Meeting
    • Place of Presentation
      New Orleans USA
    • Related Report
      2009 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi